Shandong Bailong Chuangyuan Bio-Tech Co. Ltd. (605016) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Shandong Bailong Chuangyuan Bio-Tech Co. Ltd. (605016) has a cash flow conversion efficiency ratio of 0.024x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥45.11 Million ≈ $6.60 Million USD) by net assets (CN¥1.88 Billion ≈ $274.76 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see 605016 stock market capitalisation for the company's overall valuation and market capitalisation.
Shandong Bailong Chuangyuan Bio-Tech Co. Ltd. - Cash Flow Conversion Efficiency Trend (2016–2025)
This chart illustrates how Shandong Bailong Chuangyuan Bio-Tech Co. Ltd.'s cash flow conversion efficiency has evolved over time, based on yearly financial data.
Shandong Bailong Chuangyuan Bio-Tech Co. Ltd. Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Shandong Bailong Chuangyuan Bio-Tech Co. Ltd. ranked by their cash flow conversion efficiency. Explore 605016 operating cash flow to net income to measure how well operating cash flow supports reported net income.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Rizhao Port Co Ltd
SHG:600017
|
0.017x |
|
Nuvoco Vistas Corporation Limited
NSE:NUVOCO
|
0.057x |
|
Corbion NV
AS:CRBN
|
0.038x |
|
Zhejiang Hisoar Pharmaceutical Co Ltd
SHE:002099
|
0.003x |
|
Huapont Life Sciences Co Ltd
SHE:002004
|
0.037x |
|
Shenzhen Xunjiexing Technology Corp. Ltd.
SHG:688655
|
-0.007x |
|
Camel Group Co Ltd
SHG:601311
|
0.017x |
|
Jiangling Motors Corp Ltd
SHE:000550
|
0.015x |
Annual Cash Flow Conversion Efficiency for Shandong Bailong Chuangyuan Bio-Tech Co. Ltd. (2016–2025)
The table below shows the annual cash flow conversion efficiency of Shandong Bailong Chuangyuan Bio-Tech Co. Ltd. from 2016 to 2025. View 605016 stock price and chart for real-time trading data and today's change.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | CN¥1.96 Billion ≈ $287.02 Million |
CN¥135.45 Million ≈ $19.82 Million |
0.069x | -61.46% |
| 2024-12-31 | CN¥1.68 Billion ≈ $245.73 Million |
CN¥300.89 Million ≈ $44.03 Million |
0.179x | +38.81% |
| 2023-12-31 | CN¥1.51 Billion ≈ $220.64 Million |
CN¥194.63 Million ≈ $28.48 Million |
0.129x | +15.88% |
| 2022-12-31 | CN¥1.34 Billion ≈ $196.81 Million |
CN¥149.82 Million ≈ $21.92 Million |
0.111x | +39.36% |
| 2021-12-31 | CN¥1.20 Billion ≈ $176.10 Million |
CN¥96.20 Million ≈ $14.08 Million |
0.080x | -54.65% |
| 2020-12-31 | CN¥691.09 Million ≈ $101.13 Million |
CN¥121.82 Million ≈ $17.83 Million |
0.176x | +64.25% |
| 2019-12-31 | CN¥597.07 Million ≈ $87.37 Million |
CN¥64.08 Million ≈ $9.38 Million |
0.107x | -39.58% |
| 2018-12-31 | CN¥501.71 Million ≈ $73.42 Million |
CN¥89.12 Million ≈ $13.04 Million |
0.178x | -31.68% |
| 2017-12-31 | CN¥436.41 Million ≈ $63.86 Million |
CN¥113.47 Million ≈ $16.60 Million |
0.260x | +56.90% |
| 2016-12-31 | CN¥362.67 Million ≈ $53.07 Million |
CN¥60.10 Million ≈ $8.79 Million |
0.166x | -- |
About Shandong Bailong Chuangyuan Bio-Tech Co. Ltd.
Shandong Bailong Chuangyuan Bio-Tech Co., Ltd. engages in the production and sale of food and feed additives in China and internationally. The company offers dietary fibers, including polydextrose and resistant dextrin; prebiotics, such as fructo-oligosaccharide, isomalto-oligosaccharide, galacto-oligosaccharide, and xylo-oligosaccharide. It also provides starch sugars comprising allulose, maltit… Read more